Siemens Healthineers has teamed up with Israeli start-up Healthy.io to allow patients to test their urine at home by usi...
First ever biotechnology plant will be established in Israeli southern city of Eilat to produce a new drug for AIDS dise...
Qatar Red Crescent Society (QRCS) and Qatar Diabetes Association (QDA), a member of Qatar Foundation, signed a Memorandu...
In January 2018, doctors at the Ella Lemelbaum Institute for Immuno-Oncology at Sheba Medical centre implemen...
Qatar Biomedical Research Institute (QBRI), a premier research institute under Hamad Bin Khalifa University (HBKU), has ...
Israeli biotechnology company Kadimastem, a clinical stage biotechnology company developing industrial regenerative ther...
Israeli biotech drug developer Gamida Cell Ltd. has announced that it is going public to help fund clinical trials and b...
The Dubai Health Authority (DHA) has signed a memorandum of understanding (MoU) with Nice University Hospital. The MoU ...
Atox Bio, a clinical stage biotechnology company developing novel therapies for critically ill patients has announced th...
Medtronic a global leader in medical technology, and Mazor Robotics, a pioneer in the field of robotic guidance systems,...
Shares of Israeli drugmaker Teva Pharmaceutical Industries rose over 5 percent in after-hours trading on Friday after th...
Intelyse, a Sicuro Group company recently announced that they have entered into a strategic partnership with Aspen Medic...
Leviticus Cardio an Israel company, which is inventors of the versatile transcutaneous Coplanar Energy Transfer (CET) sy...
Together Pharma, which produces medical cannabis had signed a deal to buy a controlling 50.01 percent stake ...
Researchers at the Hebrew University of Jerusalem said they have developed a new biological drug that had a 50 percent c...
UAE-based Pharmax Pharmaceuticals has begun production out of its new $34 million facility located in Dubai Science Park...
Singapore - The Directors of Ananda Developments recently announced that investee company iCAN has signed an MoU with a ...
BiondVax Pharmaceuticals Ltd., developer of the M-001 universal influenza vaccine candidate, recently reported the compa...
